Folic Acid‐Chitosan‐PLGA Nano Delivery System Against Liver Cancer Cells: In Vitro Studies
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Arianaz Hosseini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, SR.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Chitosan, Folic Acid, Liver Neoplasms, Polylactic Acid-Polyglycolic Acid Copolymer. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: The authors recieved no specific funding for this work..
Abstract (Originalsprache)
Among cancers, liver cancer is the fourth leading cause of mortality worldwide and drawbacks of conventional approaches could not inhibit this cancer. Thus, an efficient folic acid (FA)‐functionalized chitosan (CS)‐poly lactic‐co‐glycolic acid (PLGA) nanocarrier was fabricated for delivery of sodium butyrate (NB) therapeutics to HepG2 liver cancer cells. The fabricated CS‐NB‐PLGA‐FA nanocarrier was characterized by FT‐IR, DLS, TEM, and TGA. A size range of 45 nm to 80 nm, surface charge of 4.2 mV, and drug encapsulation of 15.17% were measured for nanocarrier. Controlled (about fivefolds within 2 h) and pH‐sensitive drug release manner observed in PBS as well. The MTT assay indicated that CS‐NB‐PLGA‐FA resulted in about 13% cell viability after 24 h of treatment with 400 nM concentrations (IC 50 : 300 nM). The qRT‐PCR technique revealed nearly a 7.9‐ and 5.8‐fold increase for Caspase9 and Bax genes while a decrease of about fivefold for the Bcl2 gene after treatment with CS‐NB‐PLGA‐FA. Additionally, about 60% apoptosis was observed for the cells treated with nanocarrier. Remarkable enhancement did indicate for ROS (increase in the catalase and SOD units). These data have demonstrated that CS‐NB‐PLGA‐FA could be a promising candidate against liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, SR.C., Islamic Azad University, Tehran, Iran.
- Department of Nanobiotechnology and Biomimetic, School of Life Science Engineering College of interdisciplinary Science and Technology, University of Tehran, Tehran, Iran.
- Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Javad Mohammadnejad
Förderung
- The authors recieved no specific funding for this work.
Zitieren
APA
Hosseini, A., Mohammadnejad, J., Narmani, A., & Jafari, H. (2025). Folic Acid‐Chitosan‐PLGA Nano Delivery System Against Liver Cancer Cells: In Vitro Studies. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70478
Vancouver
Hosseini A, Mohammadnejad J, Narmani A, Jafari H. Folic Acid‐Chitosan‐PLGA Nano Delivery System Against Liver Cancer Cells: In Vitro Studies. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70478
BibTeX
@article{Hosseini2025,
author = {Hosseini, Arianaz and Mohammadnejad, Javad and Narmani, Asghar and Jafari, Hanieh},
title = {Folic Acid‐Chitosan‐PLGA Nano Delivery System Against Liver Cancer Cells: In Vitro Studies},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70478}
}
EUVIMED